Tanai Therapeutics is developing a first-in-class oral therapeutic for obesity.
In stealth, more information will follow.
Axithra is developing new technology for accurate drug concentrations in blood.
CrowdScan provides accurate and privacy-friendly crowd measurement data.
ABSCINT is developing single-domain antibodies for disease diagnosis through imaging.
